These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 34541884

  • 21. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
    Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V.
    JAMA; 2013 Apr 10; 309(14):1493-501. PubMed ID: 23571588
    [Abstract] [Full Text] [Related]

  • 22. Associations of the BRAF V600E Mutation and PAQR3 Protein Expression with Papillary Thyroid Carcinoma Clinicopathological Features.
    Gao J, Ma XP, Deng FS, Jiang L, Jia WD, Li M.
    Pathol Oncol Res; 2020 Jul 10; 26(3):1833-1841. PubMed ID: 31758408
    [Abstract] [Full Text] [Related]

  • 23. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.
    Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M.
    Ann Surg Oncol; 2013 Jul 10; 20(7):2266-73. PubMed ID: 23370668
    [Abstract] [Full Text] [Related]

  • 24. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR.
    Zhang J, Yang Y, Zhao J, Shi L, Xu Y, Yu K, Guo C.
    Pathol Res Pract; 2019 Apr 10; 215(4):761-765. PubMed ID: 30819583
    [Abstract] [Full Text] [Related]

  • 25. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E, Haselmann V, Markou A, Duda A, Utikal J, Neumaier M, Lianidou ES.
    Clin Chem Lab Med; 2020 Oct 25; 58(11):1799-1807. PubMed ID: 31953992
    [Abstract] [Full Text] [Related]

  • 26. BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.
    Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson B, Gill AJ, Sywak M.
    World J Surg; 2016 Jul 25; 40(7):1618-24. PubMed ID: 27138882
    [Abstract] [Full Text] [Related]

  • 27. Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
    Zeng RC, Jin LP, Chen ED, Dong SY, Cai YF, Huang GL, Li Q, Jin C, Zhang XH, Wang OC.
    Head Neck; 2016 Apr 25; 38 Suppl 1():E1019-25. PubMed ID: 26041461
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.
    Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydın O, Altiok E, Giray S, Azizlerli H.
    Endocrine; 2012 Oct 25; 42(2):404-10. PubMed ID: 22426956
    [Abstract] [Full Text] [Related]

  • 30. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
    Onder S, Ozturk Sari S, Yegen G, Sormaz IC, Yilmaz I, Poyrazoglu S, Sanlı Y, Giles Senyurek Y, Kapran Y, Mete O.
    Endocr Pathol; 2016 Jun 25; 27(2):153-61. PubMed ID: 26951110
    [Abstract] [Full Text] [Related]

  • 31. The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.
    Kurt B, Yalçın S, Alagöz E, Karslıoğlu Y, Yigit N, Günal A, Deveci MS.
    Endocr Pathol; 2012 Sep 25; 23(3):135-40. PubMed ID: 22767446
    [Abstract] [Full Text] [Related]

  • 32. A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.
    Guerra A, Fugazzola L, Marotta V, Cirillo M, Rossi S, Cirello V, Forno I, Moccia T, Budillon A, Vitale M.
    J Clin Endocrinol Metab; 2012 Jul 25; 97(7):2333-40. PubMed ID: 22508706
    [Abstract] [Full Text] [Related]

  • 33. BRAF V600E Gene Mutation Is Associated With Bilateral Malignancy of Papillary Thyroid Cancer.
    Liu Z, Lv T, Xie C, Di Z.
    Am J Med Sci; 2018 Aug 25; 356(2):130-134. PubMed ID: 30219154
    [Abstract] [Full Text] [Related]

  • 34. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
    Gu LQ, Li FY, Zhao L, Liu Y, Zang XX, Wang TX, Chen HP, Ning G, Zhao YJ.
    Thyroid; 2009 Apr 25; 19(4):347-54. PubMed ID: 19355825
    [Abstract] [Full Text] [Related]

  • 35. BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.
    O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS.
    Surgery; 2010 Dec 25; 148(6):1139-45; discussion 1145-6. PubMed ID: 21134544
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay.
    Tran TV, Dang KX, Pham QH, Nguyen UD, Trinh NTT, Hoang LV, Ho SA, Nguyen BV, Nguyen DT, Trinh DT, Tran DN, Orpana A, Stenman UH, Stenman J, Ho TH.
    BMC Cancer; 2020 May 01; 20(1):368. PubMed ID: 32357861
    [Abstract] [Full Text] [Related]

  • 37. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.
    Pelizzo MR, Dobrinja C, Casal Ide E, Zane M, Lora O, Toniato A, Mian C, Barollo S, Izuzquiza M, Guerrini J, De Manzini N, Merante Boschin I, Rubello D.
    Biomed Pharmacother; 2014 May 01; 68(4):413-7. PubMed ID: 24721322
    [Abstract] [Full Text] [Related]

  • 38. Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.
    Gandolfi G, Sancisi V, Torricelli F, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A.
    J Clin Endocrinol Metab; 2013 May 01; 98(5):E934-42. PubMed ID: 23533235
    [Abstract] [Full Text] [Related]

  • 39. Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.
    Lu J, Gao J, Zhang J, Sun J, Wu H, Shi X, Teng L, Liang Z.
    Int J Clin Exp Pathol; 2015 May 01; 8(1):793-9. PubMed ID: 25755776
    [Abstract] [Full Text] [Related]

  • 40. Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR.
    Ashida A, Sakaizawa K, Mikoshiba A, Uhara H, Okuyama R.
    Int J Clin Oncol; 2016 Oct 01; 21(5):981-988. PubMed ID: 27041702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.